Tofflon(SZ:300171) Jin Rong Jie·2025-08-16 09:18Core Viewpoint - Shanghai Dongfulong Haiwei Biotechnology Co., Ltd. has obtained a patent for a "microfluidic technology-based nano-drug production device," indicating advancements in the field of specialized equipment manufacturing for pharmaceuticals [1] Company Overview - Shanghai Dongfulong Haiwei Biotechnology Co., Ltd. was established in 2016 and is located in Shanghai, focusing on the specialized equipment manufacturing industry [1] - The company has a registered capital of 50 million RMB [1] - According to Tianyancha data, the company has participated in 2 bidding projects and holds 66 patent records along with 4 trademark records and 5 administrative permits [1] Patent Details - The patent, authorized under announcement number CN223221374U, was applied for on July 2024 [1] - The device includes a first tank system, a second tank system, and a mixing system, designed to overcome existing deficiencies in nano-drug production [1] - The purpose of the device is to ensure thorough mixing of drugs, resulting in nano-drug products with precise size distribution and high encapsulation rates [1]